BR112013025696A2 - composição compreendendo cimento portland para utilização em vertebroplastia - Google Patents

composição compreendendo cimento portland para utilização em vertebroplastia

Info

Publication number
BR112013025696A2
BR112013025696A2 BR112013025696A BR112013025696A BR112013025696A2 BR 112013025696 A2 BR112013025696 A2 BR 112013025696A2 BR 112013025696 A BR112013025696 A BR 112013025696A BR 112013025696 A BR112013025696 A BR 112013025696A BR 112013025696 A2 BR112013025696 A2 BR 112013025696A2
Authority
BR
Brazil
Prior art keywords
portland cement
vertebroplasty
composition
weight
compositions
Prior art date
Application number
BR112013025696A
Other languages
English (en)
Inventor
Wynn-Jones Gareth
P Hofmann Michael
M Shelton Richard
Original Assignee
Spineart Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spineart Sa filed Critical Spineart Sa
Publication of BR112013025696A2 publication Critical patent/BR112013025696A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/02—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing hydraulic cements other than calcium sulfates
    • C04B28/04—Portland cements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Ceramic Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Structural Engineering (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo da patente de invenção para: “composição compreendendo cimento portland para utilização em vertebroplastia”. a presente invenção fornece uma composição de cimento para vertebroplastia que compreende uma fase sólida que compreende cimento portland e um aditivo biocompatível que é um plastificante e um acelerador de endurecimento, em que a quantidade de aditivo está compreendida entre cerca de 1% em peso e cerca de 15% em peso em relação ao cimento portland; e uma fase líquida aquosa, em que a proporção da fase sólida em relação à fase líquida está compreendida entre cerca de 3 g/ml e cerca de 6 g/ml, processos de formação de tais composições, métodos de tratamento utilizando tais composições e
BR112013025696A 2011-04-05 2012-04-05 composição compreendendo cimento portland para utilização em vertebroplastia BR112013025696A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161471999P 2011-04-05 2011-04-05
GBGB1109804.3A GB201109804D0 (en) 2011-04-05 2011-06-10 Product
PCT/GB2012/000321 WO2012136963A1 (en) 2011-04-05 2012-04-05 Composition comprising portland cement for use in vertebroplasty

Publications (1)

Publication Number Publication Date
BR112013025696A2 true BR112013025696A2 (pt) 2017-08-08

Family

ID=44357572

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025696A BR112013025696A2 (pt) 2011-04-05 2012-04-05 composição compreendendo cimento portland para utilização em vertebroplastia

Country Status (7)

Country Link
US (1) US20140060390A1 (pt)
EP (1) EP2694121A1 (pt)
JP (1) JP2014514065A (pt)
CN (1) CN103596601A (pt)
BR (1) BR112013025696A2 (pt)
GB (1) GB201109804D0 (pt)
WO (1) WO2012136963A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802863B1 (en) 2016-03-09 2017-10-31 Flashfill Services, Llc Accelerating set times of flowable fill compositions with dry calcium chloride, and methods of utilizing and producing the same
US10322971B1 (en) 2016-04-21 2019-06-18 MK1 Construction Services Fast-setting flowable fill compositions, and methods of utilizing and producing the same
US10851016B1 (en) 2017-02-28 2020-12-01 J&P Invesco Llc Trona accelerated compositions, and methods of utilizing and producing the same
US11434169B1 (en) 2018-04-25 2022-09-06 J&P Invesco Llc High-strength flowable fill compositions
US10919807B1 (en) 2018-04-25 2021-02-16 J&P Invesco Llc High-strength flowable fill compositions
CN109529107B (zh) * 2018-12-07 2021-09-03 中鼎凯瑞科技成都有限公司 多微量元素有机化合物与无机化合物通过水合桥化形成的有机-无机自凝固复合骨移植物
CN111689702B (zh) * 2020-06-22 2021-12-24 阳新娲石水泥有限公司 一种早强型抗硫酸盐水泥
JP7292572B1 (ja) * 2022-12-15 2023-06-19 諒 大槻 人工歯牙製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033367A (en) * 1978-11-07 1980-05-21 Coal Industry Patents Ltd Quick Setting Cements
US5415547A (en) 1993-04-23 1995-05-16 Loma Linda University Tooth filling material and method of use
CN101124178B (zh) * 2005-03-25 2010-11-10 创新生物陶瓷公司 水硬水泥组合物和制备及使用其的方法
US7553362B2 (en) * 2005-10-31 2009-06-30 Innovative Bioceramix, Inc. High strength biological cement composition and using the same
WO2011082258A2 (en) * 2009-12-30 2011-07-07 Regents Of The University Of Minnesota Bone cement and method

Also Published As

Publication number Publication date
JP2014514065A (ja) 2014-06-19
WO2012136963A1 (en) 2012-10-11
US20140060390A1 (en) 2014-03-06
GB201109804D0 (en) 2011-07-27
EP2694121A1 (en) 2014-02-12
CN103596601A (zh) 2014-02-19

Similar Documents

Publication Publication Date Title
BR112013025696A2 (pt) composição compreendendo cimento portland para utilização em vertebroplastia
DOP2014000115A (es) Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1
PA8848201A1 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
BR112015001618A2 (pt) composições fungicidas
BR112016018604A2 (pt) Benzimidazol-2-aminas como inibidores de midh1
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
BRPI0905733B8 (pt) composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica
SV2008003045A (es) Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes
CO6680658A2 (es) Agonista de gpr 40
BR112012032080A2 (pt) método para tamponar um furo de poço para abandono, e, composição de tamponamento
UY33735A (es) Compuestos antivirales
BR112013011448B8 (pt) Composto, composição farnmacêutica, e, uso do composto
EA201400537A1 (ru) 18-МЕТИЛ-6,7-МЕТИЛЕН-3-ОКСО-17-ПРЕГН-4-ЕН-21,17β-КАРБОЛАКТОНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЭНДОМЕТРИОЗА
BR112013029730A2 (pt) composição farmacêutica de rosuvastatina cálcica
CR20130602A (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
BR112014005025A2 (pt) composição farmacêutica para uso no tratamento de uma doença neurodegenerativa
BR112013001301A2 (pt) processo para preparar uma composição líquida farmacêutica compreendendo imunoglobulina g humana e composição líquida farmacêutica contendo imunoglobulina g humana
BR112014003640A8 (pt) métodos para perda de peso e composições cetogênicas
PA8806801A1 (es) Compuestos de amida como refuerzos de antivirales
BR112012017136A2 (pt) Composição farmacêutica compreendendo 3-beta- hidróxi-5-alfa-pregnan-20-ona com propriedades de armazenamento e solubidade aperfeiçoadas.
BR112013022448A2 (pt) estrutura com base em polietileno
BR112015009129A2 (pt) suspensão cálcio-magnesiana manejável
BR112015004523A2 (pt) compostos de tetraciclina
BR112014020113A8 (pt) Composições farmacêuticas e método para diminuir a frequência de micção
BR112015015872A2 (pt) composição de tratamento oral

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2433 DE 22-08-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.